Researchers find that temporary double-stranded DNA breaks commonly result from normal neuron activation—but expression of an Alzheimer’s-linked protein increases the damage.
Advertisement
The Scientist
Most Recent
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.
Scientists have developed new method for generating brain cells from urine, speeding up the process and eliminating some of the problems with previous techniques.
A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.
Researchers find that disrupted sleep-wake cycles could reflect or even contribute to the neurodegenerative disease.
A new study finds male genes in women’s brains, the first evidence of microchimerism in the human brain.
Researchers identify a gene variant that reduces risk of Alzheimer’s disease.
Older foraging bees experience a change in brain chemistry when they revert to nest duties typically given to younger individuals.
A protein fragment involved in Alzheimer’s can seed new clusters throughout the brain, pointing to prion-like qualities of the disease.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
